Tristen Park, MD
Assistant Professor of Surgery (Oncology, Breast)
The Park Laboratory focuses on isolating tumor infiltrating lymphocytes (TILs) from primary breast cancers with a goal of utilizing these cell lines in adoptive cell therapy for patients with advanced breast cancer. We have generated a PDX mouse model whereby we have successfully implanted tumor cells from primary breast cancers in order to monitor responsiveness of these tumors to TIL populations generated ex vivo.